Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 Nov;69(11):6847-51.
doi: 10.1128/JVI.69.11.6847-6851.1995.

Immunogenic determinants of a neuropathogenic murine leukemia virus

Affiliations

Immunogenic determinants of a neuropathogenic murine leukemia virus

D S Robbins et al. J Virol. 1995 Nov.

Abstract

Previous studies of Cas-Br-M murine leukemia virus (MuLV) (Cas-MuLV) infection demonstrated that cytotoxic T cells (CTL) of the CD8+ phenotype play a role in resistance to the neuropathogenic effects of the virus in NFS/N mice. In the current study, we sought to identify the Cas-MuLV epitopes that are immunogenic for the CTL response. Infection of adult NFS/N mice with a well-characterized neuropathogenic variant of Friend MuLV, PVC-211 MuLV (PVC-MuLV), was not immunogenic for MuLV-specific CTL. Therefore, we constructed chimeric viruses between Cas-MuLV and PVC-MuLV. Infectious chimeras contained the Cas-MuLV env gene on a PVC-MuLV background (PVC-CasenvMuLV) and the PVC-MuLV env gene on a Cas-MuLV background (Cas-PVCenvMuLV). Cas-MuLV-specific CTL were found following inoculation of both the chimeric viruses and the parental Cas-MuLV but not the parental PVC-MuLV, despite evidence of antibody responses to both parental and chimeric MuLV. CTL generated in response to infection with PVC-CasenvMuLV and Cas-PVCenvMuLV were exclusively of the CD8+ phenotype. These results indicate that both the env and gag-pol regions of Cas-MuLV express epitopes that are immunogenic for CTL.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Virology. 1970 Dec;42(4):1136-9 - PubMed
    1. J Virol. 1994 Sep;68(9):6103-10 - PubMed
    1. J Virol. 1981 Apr;38(1):239-48 - PubMed
    1. J Virol. 1983 Mar;45(3):1159-63 - PubMed
    1. J Virol. 1984 Nov;52(2):356-63 - PubMed

Publication types

MeSH terms